{"news_desk": "Business", "print_page": "", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By DAVID GELLES", "person": [{"rank": 1, "role": "reported", "firstname": "David", "organization": "", "lastname": "GELLES"}]}, "abstract": null, "type_of_material": "News", "word_count": "349", "lead_paragraph": "Teva will pay $101 a share for Auspex, which makes drugs that treat people with movement disorders.", "pub_date": "2015-03-31T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Teva to Buy Auspex, an American Drug Developer, for $3.2 Billion"}, "snippet": "Teva will pay $101 a share for Auspex, which makes drugs that treat people with movement disorders.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/03/31/business/dealbook/teva-to-buy-auspex-an-american-drug-developer-for-3-2-billion.html", "keywords": [{"rank": "1", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "2", "is_major": "N", "value": "Teva Pharmaceutical Industries Ltd", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Auspex Pharmaceuticals Inc.", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}], "blog": [], "_id": "551940b438f0d8713c6c6b43", "source": "The New York Times"}